<DOC>
	<DOCNO>NCT02143505</DOCNO>
	<brief_summary>Calcium plus vitamin D may effective prevention colorectal adenoma recurrence . The aim study investigate effect supplementation calcium plus vitamin D recurrence colorectal adenoma .</brief_summary>
	<brief_title>Study Calcium Plus Vitamin D Supplementation Prevention Colorectal Adenomas Recurrence</brief_title>
	<detailed_description>Colorectal adenomas well-known precancerous lesion develop colorectal cancer basis adenoma-carcinoma sequence . The effect screen colorectal adenoma remove precancerous lesion prevention colorectal cancer establish . Because high recurrence rate colorectal adenomas patient undergone polypectomy , potential chemopreventive agent may reduce risk colorectal adenoma recurrence need investigate . Since laboratory epidemiologic evidence suggest calcium vitamin D may help prevent colorectal adenoma , conduct randomize , placebo-controlled , prospective clinical trial study effect safety calcium plus vitamin D supplementation prevention colorectal adenoma recurrence .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>Individuals age 1865years Individuals least one histologically confirm colorectal adenoma remove within three month recruitment Individuals without history familial polyposis Those voluntarily sign consent form fully inform understand purpose procedure study , character disease , effect medication , method related examination , potential risk/benefits study Patients hypersensitive intolerant drug Patients intolerant another colonoscopy examination Patients hypercalcemia urolithiasis Pregnant woman , woman breastfeed period , woman expect pregnancy Patients diabetes mellitus , severe heart renal disease , cancer history Patients history subtotal gastrectomy partial bowel resection Patients able cooperate Individual involve designing , plan perform clinical trial Patients medical condition appropriate participate study Patients take aspirin , NSAIDs COX2 inhibitor Patients take folic acid Butyrate . Patients IBD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>